-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Titan Medical (TSE:TMD) Trading Up 7.1%
Titan Medical (TSE:TMD) Trading Up 7.1%
Titan Medical Inc. (TSE:TMD – Get Rating)'s share price was up 7.1% during mid-day trading on Tuesday . The company traded as high as C$1.24 and last traded at C$1.20. Approximately 28,127 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 58,968 shares. The stock had previously closed at C$1.12.
Titan Medical Stock Performance
The business's fifty day moving average is C$1.01 and its 200-day moving average is C$0.77. The stock has a market capitalization of C$130.91 million and a PE ratio of -10.64. The company has a quick ratio of 1.18, a current ratio of 1.41 and a debt-to-equity ratio of 21.28.
Get Titan Medical alerts:Titan Medical (TSE:TMD – Get Rating) last released its earnings results on Thursday, November 10th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, analysts anticipate that Titan Medical Inc. will post -1.9800001 EPS for the current fiscal year.
Titan Medical Company Profile
(Get Rating)Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.
See Also
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Titan Medical Inc. (TSE:TMD – Get Rating)'s share price was up 7.1% during mid-day trading on Tuesday . The company traded as high as C$1.24 and last traded at C$1.20. Approximately 28,127 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 58,968 shares. The stock had previously closed at C$1.12.
Titan Medical Inc.(TSE: TMD — 获取评级)的股价在周二午盘交易中上涨了7.1%。该公司的交易价格高达1.24加元,最后一次交易价格为1.20加元。午盘交易中约交易了28,127股,较平均每日交易量58,968股下降了52%。该股此前收于1.12加元。
Titan Medical Stock Performance
泰坦医疗股票表现
The business's fifty day moving average is C$1.01 and its 200-day moving average is C$0.77. The stock has a market capitalization of C$130.91 million and a PE ratio of -10.64. The company has a quick ratio of 1.18, a current ratio of 1.41 and a debt-to-equity ratio of 21.28.
该公司的五十天移动平均线为1.01加元,其200天移动平均线为0.77加元。该股的市值为1.3091亿加元,市盈率为-10.64。该公司的速动比率为1.18,流动比率为1.41,债务与权益比率为21.28。
Titan Medical (TSE:TMD – Get Rating) last released its earnings results on Thursday, November 10th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, analysts anticipate that Titan Medical Inc. will post -1.9800001 EPS for the current fiscal year.
Titan Medical(TSE: TMD — Get Rating)最后一次发布财报是在11月10日星期四。该公司报告了本季度每股收益(EPS)C(0.12美元)。总体而言,分析师预计,Titan Medical Inc.将在本财年公布每股收益为-1.9800001。
Titan Medical Company Profile
泰坦医疗公司简介
Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.
Titan Medical Inc是一家医疗技术公司,专注于应用于微创手术的机器人辅助手术技术的开发和商业化。它正在开发Enos系统,这是一种机器人单通道手术系统,包括由外科医生控制的患者推车,包括用于进行外科手术的三维高清视觉系统和多关节仪器;以及外科医生工作站,为外科医生提供与患者推车的人体工程学接口,并在外科手术期间提供患者体内的三维内窥镜视图。
See Also
另见
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
- 凯西·伍兹的方舟创新 ETF 将在 2023 年反弹?
- 马伦汽车股因利好消息而上涨
- 哈雷戴维森公司股票,是时候买入了吗?
- 元平台已经触底,波动性还没有结束
- 分析阿拉斯加航空的近期收益
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收《泰坦医学日报》的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Titan Medical及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧